Healthcare professionals, importers, distributors, and caregivers have been informed by the National Agency for Food and Drug Administration and Control (NAFDAC) of the recall of over 90,000 bottles of Children's Ibuprofen Oral Suspension in the United States owing to contamination concerns. The US Food and Drug Administration initiated the recall in response to concerns of foreign material in the product, the agency stated in a public advisory released on Saturday. Strides Pharma Inc. initiated the recall, according to NAFDAC, after customers reported "black particles" and a "gel-like mass" in the oral solution. Children's Ibuprofen Oral Suspension, USP (100 mg/5 mL), is frequently used to reduce fever and ease discomfort from the flu, common cold, sore throat, headache, and toothache.

The Federal Government has stepped up health surveillance measures at airports, seaports, and land borders across the country as part of efforts to prevent the importation of Ebola Virus Disease (EVD) and other viral haemorrhagic fevers. The move follows concerns over the ongoing outbreak of the Bundibugyo strain of Ebola in parts of East and Central Africa and forms part of Nigeria’s broader disease preparedness and response strategy.

The Federal High Court sitting in Abuja has affirmed the authority of the Federal Competition and Consumer Protection Commission (FCCPC) to investigate complaints involving medical negligence. Justice Emeka Nwite delivered the ruling on April 15 in a suit filed by Life Bridge Medical Diagnostic Centre Ltd, which had challenged the commission’s jurisdiction over healthcare-related complaints.